Hanx Biopharma, XtalPi Unit Enter Cooperation Contract

MT Newswires Live09-21 20:24

Hanx Biopharmaceuticals (Wuhan) (HKG:3378) entered into strategic cooperation and platform use license agreements with Shenzhen XtalPi Technology.

The parties intend to explore the application of AI for science in fields such as antibody design, innovative molecule design, and drug R&D process optimization, a Monday bourse filing showed.

Under the contract, the company will procure and use the relevant services of the XtalPi Science platform, while XtalPi will provide its with the necessary platform capabilities and technical support.

Shenzhen XtalPi Technology is a unit of biotech company XtalPi (HKG:2228).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2669630671?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-21 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2669630671","market":"nz","top_or_hot":-1,"title":"Hanx Biopharma, XtalPi Unit Enter Cooperation Contract","media":"MT Newswires Live","content":"<html><body><p> Hanx Biopharmaceuticals (Wuhan) (HKG:3378) entered into strategic cooperation and platform use license agreements with Shenzhen XtalPi Technology.</p><p>The parties intend to explore the application of AI for science in fields such as antibody design, innovative molecule design, and drug R&amp;D process optimization, a Monday bourse filing showed.</p><p>Under the contract, the company will procure and use the relevant services of the XtalPi Science platform, while XtalPi will provide its with the necessary platform capabilities and technical support.</p><p>Shenzhen XtalPi Technology is a unit of biotech company XtalPi (HKG:2228).</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hanx Biopharma, XtalPi Unit Enter Cooperation Contract</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHanx Biopharma, XtalPi Unit Enter Cooperation Contract\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-21 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hanx Biopharmaceuticals (Wuhan) (HKG:3378) entered into strategic cooperation and platform use license agreements with Shenzhen XtalPi Technology.</p><p>The parties intend to explore the application of AI for science in fields such as antibody design, innovative molecule design, and drug R&amp;D process optimization, a Monday bourse filing showed.</p><p>Under the contract, the company will procure and use the relevant services of the XtalPi Science platform, while XtalPi will provide its with the necessary platform capabilities and technical support.</p><p>Shenzhen XtalPi Technology is a unit of biotech company XtalPi (HKG:2228).</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2669630671","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2669630671","pubTimestamp":1789993467,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hanx Biopharmaceuticals   entered into strategic cooperation and platform use license agreements with Shenzhen XtalPi Technology.The parties intend to explore the application of AI for science in fields such as antibody design, innovative molecule design, and drug R&D process optimization, a Monday bourse filing showed.Under the contract, the company will procure and use the relevant services of the XtalPi Science platform, while XtalPi will provide its with the necessary platform capabilities and technical support.Shenzhen XtalPi Technology is a unit of biotech company XtalPi .","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股","BK1617":"AI医疗","03378":"翰思艾泰-B","BK1141":"生命科学工具和服务","BK1161":"生物科技","BK1535":"港口运输股","BK1173":"海港与服务"},"translate_title":"Hanx Biopharma 与 XtalPi 子公司签订合作合同","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1,"02228":1},"content_text":"Hanx Biopharmaceuticals (Wuhan) (HKG:3378) entered into strategic cooperation and platform use license agreements with Shenzhen XtalPi Technology.The parties intend to explore the application of AI for science in fields such as antibody design, innovative molecule design, and drug R&D process optimization, a Monday bourse filing showed.Under the contract, the company will procure and use the relevant services of the XtalPi Science platform, while XtalPi will provide its with the necessary platform capabilities and technical support.Shenzhen XtalPi Technology is a unit of biotech company XtalPi (HKG:2228).","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2669630671","isCrawlerRequest":true}